A Prospective Multicenter Non-interventional Cohort Study on Patients'Satisfaction With Angeliq® Micro in Real Clinical Practice Conducted in Russia
Phase of Trial: Phase IV
Latest Information Update: 23 Jul 2018
At a glance
- Drugs Estradiol/drospirenone (Primary)
- Indications Menopausal syndrome
- Focus Therapeutic Use
- Sponsors Bayer
- 16 Jul 2018 Planned End Date changed from 2 Oct 2019 to 2 Apr 2020.
- 16 Jul 2018 Planned primary completion date changed from 2 May 2019 to 2 Nov 2019.
- 22 May 2017 Status changed from not yet recruiting to recruiting.